IDEX IDEX Biometrics ASA

IDEMIA enters patent license agreement for on-card enrollment solutions with IDEX

IDEMIA enters patent license agreement for on-card enrollment solutions with IDEX

Oslo, Norway and Courbevoie, France, 3 October 2019: IDEX Biometrics ASA, the leading provider of advanced fingerprint identification and authentication solutions and IDEMIA, the global leader in Augmented Identity, have entered a worldwide license agreement for use of IDEX’s on-card biometric enrollment intellectual property. Under the terms of the agreement, IDEX has granted IDEMIA a license to use certain IDEX patents in order to develop, manufacture and sell on-card enrollment devices while benefiting from IDEMIA’s biometric card software expertise.

“On-card Enrollment” refers to enabling a user to enroll onto a brand new biometric smart card in their own home. The card-holder may receive a new biometric smart card and a light-weight receptacle containing a power source through the mail. The user then inserts the card into the enrollment receptacle and simply touches the fingerprint sensor area on the card several times. Throughout the enrollment process, the card is not connected to any other device or network. With no need to visit a bank, no need to involve another device, no apps, no wireless pairing and no compatibility problems for the user to worry about, on-card enrollment is a cost-effective, practical solution that is championing over alternative connected enrollment methods.

Earlier this year, IDEX was granted foundational patents for devices and methods relating to on-card enrollment on biometric smart cards by the United States Patent and Trademark Office and IP Australia. IDEX also has additional patent applications for its enrollment inventions pending in other major territories. These patents form part of a broad portfolio of patents and applications on fingerprint sensor and biometric algorithm technology which IDEX is using to enable the expansion of the biometric smart card and payment card markets.

Today’s announcement deepens a long-standing collaboration between IDEX and IDEMIA to capitalize on IDEMIA’s biometry technology and card manufacturing expertise in order to develop biometric smart cards that can be supported by IDEX’s on-card fingerprint enrollment patents.Through this new license agreement, IDEMIA, with the support of IDEX, is taking another step towards democratizing biometric security and can now offer personalized card enrollment solutions to its network of customers.

Dave Orme, SVP of Sales and Marketing at IDEX comments: “IDEX Biometrics started filing its first patent applications for on-card enrollment concepts in 2017. Since then, this disruptive invention has grown in popularity throughout the payment industry and represents a key enabler for biometric smart card adoption. We’re delighted to be licensing this unique and innovative solution to IDEMIA as we continue to work closely together to enable mass adoption of biometric smart cards.”

Amanda Gourbault, Executive VP of the Financial Institutions Business Unit at IDEMIA said: “Our expertise and technology at IDEMIA make it possible to offer secure payment methods and to respond to customers’ growing demand for biometric authentication. Using biometrics to secure point of sale transactions reduces friction in the payment experience as well as providing the best security to carry out transactions with complete trust.”

For further information contact:

Stuart Hunt, Head of Investor Relations & Communications

+44 (0)1276 534 632

Anne McAleer, Sr. Director, Intellectual Property

+44 (0)7900 279 473

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX), is the leading provider of fingerprint identification technologies offering simple, secure and personal authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings with the touch of a finger. We invent, engineer and commercialize these secure, yet incredibly user-friendly solutions. Our total addressable market represents a fast-growing multi-billion-unit opportunity.

For more information, visit and follow @IDEXBiometrics on Twitter.

About IDEMIA

IDEMIA, the global leader in Augmented Identity, provides a trusted environment enabling citizens and consumers alike to perform their daily critical activities (such as pay, connect and travel), in the physical as well as digital space.

Securing our identity has become mission critical in the world we live in today. By standing for Augmented Identity, an identity that ensures privacy and trust and guarantees secure, authenticated and verifiable transactions, we reinvent the way we think, produce, use and protect one of our greatest assets – our identity – whether for individuals or for objects, whenever and wherever security matters. We provide Augmented Identity for international clients from Financial, Telecom, Identity, Public Security and IoT sectors. With 13,000 employees around the world, IDEMIA serves clients in 180 countries.

For more information, visit / Follow @IdemiaGroup on Twitter.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

EN
03/10/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX Biometrics ASA

 PRESS RELEASE

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - ...

IDEX Biometrics ASA – EX. SHARE CONSOLIDATION (REVERSE SPLIT) TODAY - 9 Jan 2024 Issuer name: IDEX Biometrics ASA Ex. date: 9 January 2024 Type of corporate action: Share consolidation (reverse split) Previous ISIN: NO0003070609 New ISIN: NO0013107490 For further information contact:Marianne Bøe, Investor RelationsE-mail: Tel: About this noticeThis notice was published by Erling Svela, Vice president of finance, on 9 January 2024 at 08:00 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to Continuing Obligations at Oslo Børs Euronext and is published ...

 PRESS RELEASE

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024

IDEX Biometrics ASA – EX. AKSJESPLEIS I DAG – 9. januar 2024 Utstedernavn: Idex Biometrics ASA Ex. Dato: 9. januar 2024 Type selskapshandling: Aksjespleis Tidligere ISIN: NO0003070609 Ny ISIN: NO0013107490 For ytterligere informasjon kontact:Marianne Bøe, investorkontaktE-mail: Tel: Om denne meldingenDenne meldingen ble publisert av økonomisjef Erling Svela den 9. januar 2024 kl 08:00 CET på vegne av IDEX Biometrics ASA. Informasjonen skal offentligjøres iht løpende forpliktelser ved Oslo Børs Euronext og utsendes i tråd med paragraf 5‑12 i verdipapirhandelloven.

 PRESS RELEASE

Registration of share consolidation (reverse split) in IDEX Biometrics...

Registration of share consolidation (reverse split) in IDEX Biometrics - 8 Jan 2024 Reference is made to the notice on 21 December 2023 about the five-to-one share consolidation (reverse split) resolved by the extraordinary general meeting on the same day, agenda item 3. The consolidation has been registered. Following the registration, the company's share capital remains NOK 209,551,597.50, but is now divided into 279,402,130 shares, each with a nominal value of NOK 0.75. For the avoidance of doubt, the registration does not affect the dates set forth in the notice of key informatio...

 PRESS RELEASE

Registration of share capital increase in IDEX Biometrics 29 Dec 2023

Registration of share capital increase in IDEX Biometrics 29 Dec 2023 Reference is made to the notice on 22 December 2023 regarding issue of two shares  at NOK 0.15 per shareto an employee of the company as part of the five-to-one share consolidation resolved by the extraordinary general meeting on 21 December 2023, agenda item 3. The consolidation of shares will take place on or about 10 January 2024. Reference is made to the notice of the extraordinary general meeting issued on 30 November 2023 and the notice of resolutions made by the extraordinary general meeting issued on 21 December 2...

 PRESS RELEASE

IDEX Biometrics convertible loan agreement completed 28 Dec 2023

IDEX Biometrics convertible loan agreement completed 28 Dec 2023 Reference is made to the notice by IDEX Biometrics ASA on 26 December 2023 that the convertible loan agreement had been entered into. All closing conditions have now been met and satisfied and closing of the convertible bond transaction has been completed. The initial conversion price, NOK 0.7330 per share, was correctly stated in the notice, but the calculation basis should have been phrased as follows: “The initial conversion price will be NOK 0.7330 per share, which is 125% of the lowest volume weighted average price (VWAP...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch